Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis
Download
Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personal.pdf
- Published Version
(3MB)
| Preview
Available under license: Creative Commons Attribution
Export
Rodi, Maria ORCID: 0000-0001-6578-0851, de Lastic, Anne-Lise ORCID: 0000-0002-3152-4777, Panagoulias, Ioannis, Aggeletopoulou, Ioanna ORCID: 0000-0003-4489-1485, Kelaidonis, Kostas, Matsoukas, John ORCID: 0000-0001-5554-2964, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Mouzaki, Athanasia ORCID: 0000-0001-5548-7002 (2024) Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. International Journal of Molecular Sciences, 25 (11). ISSN 1661-6596 (print) 1422-0067 (online)
Dimensions Badge
Altmetric Badge
Item type | Article |
URI | https://vuir.vu.edu.au/id/eprint/48919 |
DOI | 10.3390/ijms25116092 |
Official URL | https://www.mdpi.com/1422-0067/25/11/6092 |
Subjects | Current > FOR (2020) Classification > 3202 Clinical sciences Current > FOR (2020) Classification > 3204 Immunology Current > Division/Research > Institute for Health and Sport |
Keywords | peptides; MOG35–55; mannan; vitamin D; dendritic cells; cytokines; regulatory T cells; immunomodulation; human |
Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)